# Cannabis Retailer Advice on Blunt, Tobacco, and Cannabis Use During Pregnancy > **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637) > **Publisher:** CED Clinic (https://cedclinic.com) > **Canonical URL:** https://cedclinic.com/pregnancy-cannabis-counseling-patient-safety/ > **Published:** 2026-03-26T09:02:12-04:00 | **Last Modified / Clinically Audited:** 2026-09-28T10:38:05-04:00 > **Clinical Summary:** Explore pregnancy cannabis counseling patient safety and the risks of prenatal cannabis use advised by cannabis retailers. Learn evidence-based guidance here. --- CED Clinical Relevance  #56Monitored Relevance  Early-stage or contextual signal requiring further evidence before action. 🔬 Evidence Watch  |  CED Clinic PregnancyCannabis CounselingPatient SafetyPrenatal CareHealthcare Communication Journal JAMA network open Study Type Clinical Study Population Human participants Why This Matters Pregnant patients increasingly turn to cannabis retailers for medical advice, yet these staff members lack clinical training to provide evidence-based guidance on prenatal [cannabis safety](https://cedclinic.com/respiratory-effects-inhalational-marijuana/). This study reveals a critical gap in the information ecosystem that could influence maternal and fetal health decisions. Clinical Summary This cross-sectional study used mystery shoppers to evaluate advice given by California cannabis retailers (budtenders) to pregnant individuals inquiring about prenatal cannabis, blunt, and tobacco use safety. The study examined whether recommendations varied based on mental health indications versus general use, and assessed differences between storefront and delivery services. The research highlights the disconnect between retail cannabis advice and established medical evidence regarding prenatal substance use risks. Dr. Caplan’s Take “This study confirms what I observe clinically—patients are seeking cannabis guidance from retail staff who are neither trained nor qualified to provide medical advice, particularly regarding pregnancy safety. The retail environment creates a false sense of medical authority that can lead to potentially harmful decisions.” Clinical Perspective 🧠 Clinicians should proactively discuss [cannabis use](https://cedclinic.com/cannabis-cardiovascular-health-insights-2024/) with pregnant patients and establish themselves as the primary source for evidence-based prenatal substance use guidance. Patients should be counseled that retail cannabis staff cannot provide medical advice, and any [cannabis use](https://cedclinic.com/cannabis-cardiovascular-health-insights-2024/) during pregnancy should be discussed with their healthcare provider given current safety data limitations. 💬 Join the Conversation Have a question about how this applies to your situation? [Ask Dr. Caplan →](https://benjamincaplan.com/ask-dr-caplan) Want to discuss this topic with other patients and caregivers? [Join the forum discussion →](https://cedclinic.com/interact/discussion-forums/) Have thoughts on this? Share it: [𝕏 Share on X](https://twitter.com/intent/tweet?text=Just%20read%20this%20on%20CEDclinic.com%3A%20Cannabis%20Retailer%20Advice%20on%20Blunt%2C%20Tobacco%2C%20and%20Cannabis%20Use%20During%20Pregnancy.%20%40drcaplan&url=https%3A//pubmed.ncbi.nlm.nih.gov/41370076/)[in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A//pubmed.ncbi.nlm.nih.gov/41370076/)[🦥 Share on BlueSky](https://bsky.app/intent/compose?text=Just%20read%20this%3A%20Cannabis%20Retailer%20Advice%20on%20Blunt%2C%20Tobacco%2C%20and%20Cannabis%20Use%20During%20Pregnancy.%20--%20via%20%40drcaplan.bsky.social%20https%3A//pubmed.ncbi.nlm.nih.gov/41370076/)[📷 Follow on Instagram](https://www.instagram.com/drbenjamincaplan/)[📝 Read more on Substack](https://substack.com/@doctorapproved)[🔔 Subscribe via RSS](https://cedclinic.com/category/cannabis-news/feed/) 📰 Source: [https://pubmed.ncbi.nlm.nih.gov/41370076/](https://pubmed.ncbi.nlm.nih.gov/41370076/) Table of Contents - [FAQ](#FAQ)[Should healthcare providers be concerned about patients receiving cannabis advice from budtenders during pregnancy?](#Should_healthcare_providers_be_concerned_about_patients_receiving_cannabis_advice_from_budtenders_during_pregnancy) - [What makes budtender advice particularly concerning for pregnant patients?](#What_makes_budtender_advice_particularly_concerning_for_pregnant_patients) - [How should clinicians address prenatal cannabis use when patients mention budtender recommendations?](#How_should_clinicians_address_prenatal_cannabis_use_when_patients_mention_budtender_recommendations) - [Does the indication for cannabis use affect the safety advice budtenders provide to pregnant customers?](#Does_the_indication_for_cannabis_use_affect_the_safety_advice_budtenders_provide_to_pregnant_customers) - [What patient safety implications does this study highlight for prenatal care?](#What_patient_safety_implications_does_this_study_highlight_for_prenatal_care) - [Related](#Related) ## FAQ #### Should healthcare providers be concerned about patients receiving cannabis advice from budtenders during pregnancy? Yes, this study reveals that pregnant individuals may view budtenders as trusted sources of information about [prenatal cannabis use](https://cedclinic.com/placental-biology-prenatal-thc-exposure-schizophrenia-risk/) safety. Healthcare providers should proactively discuss cannabis use with pregnant patients, as budtenders lack medical training and may provide advice that conflicts with clinical guidelines. #### What makes budtender advice particularly concerning for pregnant patients? Budtenders are retail employees without medical training who may have financial incentives to recommend products. This study demonstrates they provide guidance on prenatal substance use safety, including tobacco and cannabis, despite lacking the clinical expertise to assess maternal and fetal risks. #### How should clinicians address prenatal cannabis use when patients mention budtender recommendations? Clinicians should provide non-judgmental, evidence-based counseling about the potential risks of prenatal cannabis exposure to [fetal development](https://cedclinic.com/prenatal-cannabinoid-exposure-reproductive-health-insights/). It’s important to acknowledge patient concerns while clearly distinguishing between retail advice and medical recommendations based on current research. #### Does the indication for cannabis use affect the safety advice budtenders provide to pregnant customers? The study examined whether budtender recommendations varied based on mental health versus other indications for use. This suggests that budtenders may tailor their advice based on perceived medical need, despite lacking clinical training to make such determinations. #### What patient safety implications does this study highlight for prenatal care? This research underscores the need for enhanced communication between healthcare providers and pregnant patients about cannabis use. Providers should create safe spaces for discussing substance use and ensure patients receive accurate, medically-informed guidance rather than relying on retail recommendations. {“@context”: “https://schema.org”, “@type”: “ScholarlyArticle”, “headline”: “Cannabis Retailer Advice on Blunt, Tobacco, and Cannabis Use During Pregnancy.”, “url”: “https://pubmed.ncbi.nlm.nih.gov/41370076/”, “about”: “jama network open clinical study cannabis”, “isPartOf”: “JAMA network open”} [https://cedclinic.com/contact/](https://cedclinic.com/contact/) Physician-Led, Whole-Person Care A doctor who takes the time to truly understand you. Personal care that starts with listening and is guided by experience and ingenuity. Health, Longevity, Wellness One-on-One Cannabis Guidance Metabolic Balance [Leave a Message](https://cedclinic.com/contact/) [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/) [Medical Consulting](https://cedclinic.com/book/) [Cannabis Care](https://cedclinic.com/book/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) RELATED READING AT CED CLINIC Continue exploring the evidence [Perceived Safety of Cannabis Use During Pregnancy and Changes in Perception over Time (2017-2021)](https://cedclinic.com/perceived-cannabis-safety-pregnancy-survey-2017-2021/) A national survey exploring how perceptions of [cannabis safety](https://cedclinic.com/respiratory-effects-inhalational-marijuana/) during pregnancy have evolved among US adults. [Read Survey Insights](https://cedclinic.com/perceived-cannabis-safety-pregnancy-survey-2017-2021/) [Cannabis Retailer Advice on Blunt, Tobacco, and Cannabis Use During Pregnancy](https://cedclinic.com/cannabis-budtender-advice-pregnancy-safety-study/) Study evaluating the advice given by cannabis retailers to pregnant individuals regarding prenatal cannabis and tobacco use safety. [Explore Study Findings](https://cedclinic.com/cannabis-budtender-advice-pregnancy-safety-study/) [The Effects of Extended Cannabis Abstinence in Comorbid Posttraumatic Stress Disorder and Cannabis Use Disorder](https://cedclinic.com/cannabis-cessation-ptsd-dual-diagnosis-effects/) Research on cannabis abstinence effects in patients with PTSD and [cannabis use disorder](https://cedclinic.com/sex-differences-cannabis-stress-reactivity-oxytocin/), relevant for understanding cannabis impact on mental health. [Learn More](https://cedclinic.com/cannabis-cessation-ptsd-dual-diagnosis-effects/) ### Related --- ### Verification & Medical Governance - **Lead Clinical Author:** Benjamin Caplan, MD - **Credentials:** Board Certified in Family Medicine (ABFM), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House). - **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`). - **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/). - **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637). - **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).